Ibnsina Pharma ranked first in non-pharma product distribution across pharmacies in Egypt during the first nine months of ...
ORLANDO, FLORIDA / ACCESS Newswire / October 31, 2025 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) and NDT Pharmaceuticals Inc. (OTC:NDTP) on the RedChip ...
Fusen Pharmaceutical Co., Ltd. ( ($HK:1652) ) has shared an update. Fusen Pharmaceutical Co., Ltd. announced that its Metformin Empagliflozin ...
New Delhi: Aurobindo Pharma on Wednesday posted a 4 per cent increase in its consolidated net profit to Rs 848 crore for the ...
Clever Culture is bringing automation to pharma microbiology, with its AI tech now used by global heavyweights such as ...
President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how ...
Shandong Xinhua Pharmaceutical Company Limited Class H ( ($HK:0719) ) has provided an announcement. Shandong Xinhua Pharmaceutical Company Limited ...
Arjun and Preethi discuss the impact of product review cycles on pharma stocks, focusing on Dr. Reddy's recent challenges.
Teva Pharmaceuticals USA, based in Parsippany, New Jersey, issued a voluntary recall on Oct. 7 for some of the prazosin ...
A meeting of the board of directors of the company will be held on November 13, 2025, to consider and approve the unaudited ...
Natco Pharma on Friday announced launch of Everolimus tablets 1mg, a generic version of Novartis’ immunosuppressant Zortress.
As of September 30, 2025, Corvus had cash, cash equivalents and marketable securities of $65.7 million as compared to $52.0 million as of December 31, 2024. Consistent with last quarter, Corvus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results